Trials that use: Covariate adjustment
3,055 results
- 1% Chloroprocaine(PF) vs. Bupivacaine Spinals: Complete Statistical AnalysisIndependent statistical analysis of 1% Chloroprocaine(PF) vs. Bupivacaine Spinals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03324984).
- 12 Month Open Extension of TNS for ADHD.: Complete Statistical AnalysisIndependent statistical analysis of 12 Month Open Extension of TNS for ADHD.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03888391).
- 12- Week Open Label Treatment of Refractory Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of 12- Week Open Label Treatment of Refractory Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00223496).
- 12-Month Stability of Diurnal IOP Control on Cosopt: Complete Statistical AnalysisIndependent statistical analysis of 12-Month Stability of Diurnal IOP Control on Cosopt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00379834).
- 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.: Complete Statistical AnalysisIndependent statistical analysis of 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D): Complete Statistical AnalysisIndependent statistical analysis of 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma: Complete Statistical AnalysisIndependent statistical analysis of 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 1974Independent statistical analysis of Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.: Complete Statistical AnalysisIndependent statistical analysis of 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD: Complete Statistical AnalysisIndependent statistical analysis of 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01404208).
- 24-hour Blood Pressure Measurements and Ischemic Conditioning: Complete Statistical AnalysisIndependent statistical analysis of 24-hour Blood Pressure Measurements and Ischemic Conditioning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03303404).
- 28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study: Complete Statistical AnalysisIndependent statistical analysis of 28 mm Ceramic-on-Ceramic Acetabular Cup Total Hip Replacement Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00208507).
- 2CAREIndependent statistical analysis of Coenzyme Q10 in Huntington's Disease (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00608881).
- 306A/306BIndependent statistical analysis of A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- 32543Independent statistical analysis of Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01027806).
- 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets: Complete Statistical AnalysisIndependent statistical analysis of 36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- 3CIndependent statistical analysis of Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01120028).
- 3Dvs2DforUCIndependent statistical analysis of Evaluation of 3D Visualization for Total Colectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02370056).
- 3MVIndependent statistical analysis of Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 4 Pillars Toolkit for Adolescent Vaccination: Complete Statistical AnalysisIndependent statistical analysis of 4 Pillars Toolkit for Adolescent Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165722).
- 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis: Complete Statistical AnalysisIndependent statistical analysis of 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- 437_EsComIndependent statistical analysis of Community Spirit in Residence for the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06441877).
- 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period: Complete Statistical AnalysisIndependent statistical analysis of 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension: Complete Statistical AnalysisIndependent statistical analysis of 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 65plusIndependent statistical analysis of Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension: Complete Statistical AnalysisIndependent statistical analysis of 8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension: primary endpoint results, effect estimate with confidence…
- 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01247285).
- 90° Rotation Technique for LMA FlexibleTM Insertion: Complete Statistical AnalysisIndependent statistical analysis of 90° Rotation Technique for LMA FlexibleTM Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03028896).
- A “Real World” Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM): Complete Statistical AnalysisIndependent statistical analysis of A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.: Complete Statistical AnalysisIndependent statistical analysis of A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD…
- A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation: Complete Statistical AnalysisIndependent statistical analysis of A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation: primary endpoint results,…
- A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY: Complete Statistical AnalysisIndependent statistical analysis of A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY: primary endpoint results,…
- A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children…
- A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica: Complete Statistical AnalysisIndependent statistical analysis of A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval,…
- A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients: Complete Statistical AnalysisIndependent statistical analysis of A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD): Complete Statistical AnalysisIndependent statistical analysis of A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD): primary endpoint results, effect estimate with confidence interval, sample-size…
- A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease: Complete Statistical AnalysisIndependent statistical analysis of A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate…
- A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05515601).
- A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate: Complete Statistical AnalysisIndependent statistical analysis of A Challenge Study to Assess the Safety, Immunogenicity and Efficacy of a Malaria Vaccine Candidate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Chatbot Intervention for Reducing HPV Vaccine Hesitancy: Complete Statistical AnalysisIndependent statistical analysis of A Chatbot Intervention for Reducing HPV Vaccine Hesitancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05959564).
- A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Clinical Comparison of Two Daily Disposable Soft Contact Lenses: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Comparison of Two Daily Disposable Soft Contact Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04005885).
- A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD): primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Outcome Study of Two Multifocal Intraocular Lenses (IOL) in Cataract Patients: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Outcome Study of Two Multifocal Intraocular Lenses (IOL) in Cataract Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…